Table 4 Comparison of SVA parameters and additional parameters of DVA between dialysis patients and healthy individuals.

From: Endothelial dysfunction in retinal vessels of hemodialysis patients compared to healthy controls

 

Whole cohorts

Matched cohorts§

Healthy*

Hemodialysis*

p-value†

Healthy*

Hemodialysis*

p-value†

aMax, %

2.3 [0.7–4.1]

1.6 [0.3–3.3]

0.009

2.2 [0.8–4.1]

1.6 [0.3–3.3]

0.023

vMax, %

3.7 [2.4–5.4]

3.2 [2.0–5.1]

0.053

3.8 [2.4–5.5]

3.2 [1.9–5.1]

0.019

CRAE, MU

175 [165–185]

176 [165–185]

0.998

176 [165–185]

176 [164–186]

0.838

CRVE, MU

209 [196–220]

208 [196–220]

0.667

208 [195–220]

209 [196–223]

0.534

AVR

0.84 [0.80–0.88]

0.84 [0.80–0.89]

0.703

0.84 [0.81–0.88]

0.84 [0.79–0.88]

0.589

  1. aMax maximum arteriolar dilation, vMax maximum venular dilation, CRAE central retinal arterial equivalent, CRVE central retinal venous equivalent, AVR arterio-venous ratio.
  2. †Significant differences are marked bold (p < 0.05).
  3. *Data displayed as median [IQR].
  4. §Matching for DVA parameters for age (n = 169 vs 169); matching for SVA parameters for age and gender (n = 168 vs 168).
Back to article page